Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.

Walter SpindelboeckBettina HalwachsNadine BayerBianca Huber-KrassnitzerEduard SchulzBarbara UhlLukas GakschStefan HatzlVictoria BachmayrLisa KleisslPatrizia KumpAlexander DeutschGeorg StaryHildegard GreinixGregor GorkiewiczChristoph HögenauerPeter Neumeister

Published in: Therapeutic advances in hematology (2021)

This study increases the knowledge about the crucial effects of antibiotics in patients given FMT for treatment refractory GI-GvHD and defines the characteristic alterations of ileocolonic mucosal immune cells in this setting.

Keyphrases

end stage renal disease
ejection fraction
healthcare
newly diagnosed
allogeneic hematopoietic stem cell transplantation
prognostic factors
stem cells
mesenchymal stem cells
acute myeloid leukemia